NKTR
Nektar Therapeutics · Healthcare
President and CEO Howard W Robin sold $137K of Nektar Therapeutics
Sold$136,656
$10.95Price
12,480Shares
−2%Stake
What NKTR did after the filing
- The stock from Fri, Feb 18 close, $158.25
- −45.7%
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Apr 4 close.
Traded Wed, Feb 16. Filed Fri, Feb 18, 1:16 PM ET, during the session. Returns use the Feb 18 close and the Apr 4 close. Not investment advice.